Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock factor 1 (HSF1) mRNA is the messenger RNA transcript that encodes the HSF1 protein, which serves as the master transcriptional regulator of the heat shock response in eukaryotic cells (Source: UniProt P10892). The HSF1 protein is critical for maintaining proteostasis by inducing the expression of molecular chaperones, such as HSP70 and HSP90, which assist in protein folding and prevent the aggregation of damaged proteins during cellular stress (Source: NIH Gene ID 3297). In many cancers, HSF1 is constitutively active or overexpressed, providing a survival advantage to malignant cells by helping them cope with the proteotoxic stress caused by rapid proliferation, aneuploidy, and a hostile tumor microenvironment (Source: Mendillo et al., Cell, 2012). Because the HSF1 protein lacks a traditional ligand-binding pocket and is considered difficult to target with small molecules, its mRNA has become a primary focus for nucleic acid-based therapeutics. Drugs like TKM-HSF1 utilize RNA interference (RNAi) to specifically degrade HSF1 mRNA, effectively silencing the production of the HSF1 protein and sensitizing cancer cells to apoptosis (Source: Arbutus Biopharma; Santagata et al., Science, 2013). This strategy aims to disrupt the 'non-oncogene addiction' of cancer cells to the heat shock response while potentially sparing normal cells that are less dependent on high levels of HSF1.
RNA interference (RNAi) or antisense-mediated degradation of mRNA to prevent translation of the HSF1 protein (Source: Arbutus Biopharma; Santagata et al., Science, 2013).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock factor 1 (HSF1) mRNA (HSF1 mRNA).